Most firms struggle to capture real value from AI not because the technology fails—but because their people, processes, and politics do. Survey data and case studies demonstrate how fear of ...
(Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework ...